Dilated cardiomyopathy differential diagnosis: Difference between revisions

Jump to navigation Jump to search
 
(12 intermediate revisions by the same user not shown)
Line 4: Line 4:


==Overview==
==Overview==
Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular acute coronary syndrome, other cardiomyopathies (hypertrophic, restrictive, and ARVC/D), myocarditis, pericarditis, and cardiac toxicities.   
[[Dilated cardiomyopathy]] should be differentiated from other causes of cardiac dysfunction, in particular [[Acute coronary syndromes|acute coronary syndrome]], other cardiomyopathies ([[Hypertrophic cardiomyopathy|hypertrophic]], restrictive, and ARVC/D), myocarditis, [[pericarditis]], and cardiac toxicities.   


==Differentiating Dilated Cardiomyopathy from other Diseases==
==Differentiating Dilated Cardiomyopathy from other Diseases==
Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular [[Acute coronary syndromes|acute coronary syndrome]], other [[Cardiomyopathy|cardiomyopathies]] ([[Hypertrophic cardiomyopathy|hypertrophic]], [[Restrictive Cardiomyopathies|restrictive]], and ARVC/D), [[myocarditis]], [[pericarditis]], and cardiac toxicities.<ref name="pmid1507837">{{cite journal| author=Amosova EN| title=[Differential diagnosis of dilated cardiomyopathy]. | journal=Klin Med (Mosk) | year= 1992 | volume= 70 | issue= 3-4 | pages= 14-9 | pmid=1507837 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1507837  }}</ref><ref name="pmid31073128">{{cite journal| author=Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE et al.| title=Dilated cardiomyopathy. | journal=Nat Rev Dis Primers | year= 2019 | volume= 5 | issue= 1 | pages= 32 | pmid=31073128 | doi=10.1038/s41572-019-0084-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31073128  }}</ref><ref name="pmid14598597">{{cite journal| author=Gurevich MA, Gordienko BV| title=[Dilated and ischemic cardiomyopathy: differential diagnosis]. | journal=Klin Med (Mosk) | year= 2003 | volume= 81 | issue= 9 | pages= 68-71 | pmid=14598597 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14598597  }}</ref><ref name="pmid145985972">{{cite journal| author=Gurevich MA, Gordienko BV| title=[Dilated and ischemic cardiomyopathy: differential diagnosis]. | journal=Klin Med (Mosk) | year= 2003 | volume= 81 | issue= 9 | pages= 68-71 | pmid=14598597 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14598597  }}</ref>  
[[Dilated cardiomyopathy]] should be differentiated from other causes of cardiac dysfunction, in particular [[Acute coronary syndromes|acute coronary syndrome]], other [[Cardiomyopathy|cardiomyopathies]] ([[Hypertrophic cardiomyopathy|hypertrophic]], [[Restrictive Cardiomyopathies|restrictive]], and ARVC/D), [[myocarditis]], [[pericarditis]], and cardiac toxicities.<ref name="pmid1507837">{{cite journal| author=Amosova EN| title=[Differential diagnosis of dilated cardiomyopathy]. | journal=Klin Med (Mosk) | year= 1992 | volume= 70 | issue= 3-4 | pages= 14-9 | pmid=1507837 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1507837  }}</ref><ref name="pmid31073128">{{cite journal| author=Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE et al.| title=Dilated cardiomyopathy. | journal=Nat Rev Dis Primers | year= 2019 | volume= 5 | issue= 1 | pages= 32 | pmid=31073128 | doi=10.1038/s41572-019-0084-1 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31073128  }}</ref><ref name="pmid14598597">{{cite journal| author=Gurevich MA, Gordienko BV| title=[Dilated and ischemic cardiomyopathy: differential diagnosis]. | journal=Klin Med (Mosk) | year= 2003 | volume= 81 | issue= 9 | pages= 68-71 | pmid=14598597 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14598597  }}</ref><ref name="pmid145985972">{{cite journal| author=Gurevich MA, Gordienko BV| title=[Dilated and ischemic cardiomyopathy: differential diagnosis]. | journal=Klin Med (Mosk) | year= 2003 | volume= 81 | issue= 9 | pages= 68-71 | pmid=14598597 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14598597  }}</ref>  
{| class="wikitable"
{| class="wikitable"
|+
|+
Line 14: Line 14:
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical Presentation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Clinical Presentation
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Laboratory Findings
!Electrocardiogram
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Electrocardiogram
!Echocardiography
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Echocardiography
|-
|[[Dilated cardiomyopathy|Dilated Cardiomyopathy]]
|
* Idiopathic
* [[Myocarditis]]
* [[Substance abuse]]
* Connective tissue disease
* [[Nutritional deficiencies]]
* Infiltrative diseases
* [[Toxin|Toxins]].
|
* Lateral displacement of the [[Displaced point of maximal impulse|point of maximal impulse]]
* Right ventricular heave
 
* [[S2|S<sub>2</sub>]] at the base
 
* [[Gallop rhythm|S3 gallop]]<nowiki/>s
 
* [[Jugular venous distension]]
 
* [[Peripheral edema]]
|
* Detecting the cause (such as [[thyroid function tests]], [[Toxicology screen (patient information)|toxicology screen]]<nowiki/>ing, and [[Genetic counseling|genetic counselling]])
 
* Assessing the cardiac [[Complication (medicine)|complications]] of the condition
|
* Left [[ventricular hypertrophy]]
* [[Atrial fibrillation]] or [[premature ventricular complex]]<nowiki/>es
* Conduction delays, [[Atrioventricular block|AV nodal block]], or [[left bundle branch block]]
|
* Ventricular and atrial dilatation
 
* Increased left ventricular mass
 
* Global reduction in systolic function
 
* Focal wall motion abnormalities
|-
|-
|[[Acute coronary syndromes|Acute Coronary Syndrome]]
|[[Acute coronary syndromes|Acute Coronary Syndrome]]
|
|
* [[Atherosclerosis]]
*[[Atherosclerosis]]
* [[Coronary artery thrombus|Coronary thrombosis]]
*[[Coronary artery thrombus|Coronary thrombosis]]
* [[Plaque rupture]]
*[[Plaque rupture]]
|
|
* [[Chest pain|Chest Pain]]
*[[Chest pain|Chest Pain]]
* [[Dyspnea]]
* [[Dyspnea]]
* [[Palpitation|Palpitations]]
*[[Palpitation|Palpitations]]
* [[Nausea and vomiting|Nausea]], vomiting, and [[Perspiration|sweating]]
*[[Nausea and vomiting|Nausea]], vomiting, and [[Perspiration|sweating]]
|
|
* Elevated blood [[troponin]] levels (after 6 hours of attack onset)
* Elevated blood [[troponin]] levels (after 6 hours of attack onset)
* Elevated blood [[CK-MB]] levels
* Elevated blood [[CK-MB]] levels
|
|
* [[ST segment]] changes  
*[[ST segment]] changes


* T wave changes
*[[T wave]] changes


* Pathological Q waves.
* Pathological [[Q wave]]<nowiki/>s.
|
|
* Segmental wall motion abnormalities: Location and extent of [[ischemia]]
* Diagnosis of mechanical complications
*[[ST elevation myocardial infarction risk stratification and prognosis|Risk stratification]]
|-
|-
|Acute [[Pericarditis]]
|Acute [[Pericarditis]]
|
|
* Idiopathic
* Idiopathic
* [[Viral infection]]
*[[Viral infection]]
* Connective tissue diseases (e.g. [[SLE]])
* Connective tissue diseases (e.g. [[SLE]])
* [[Dressler's syndrome|Dressler's Syndrome]] (after MI)
*[[Dressler's syndrome|Dressler's Syndrome]] (after MI)
* [[Familial mediterranean fever|Familial Mediterranean fever]]
*[[Familial mediterranean fever|Familial Mediterranean fever]]
|
|
* Sharp [[chest pain]] (that increases with breathing/[[cough]], reduced with leaning forward)
* Sharp [[chest pain]] (that increases with breathing/[[cough]], reduced with leaning forward)
* [[Pericardial friction rub]]
*[[Pericardial friction rub]]
* [[Fever]] (for inflammatory causes)
*[[Fever]] (for inflammatory causes)
|
|
*[[Complete blood count|CBC]]: Increased WBCs count
*[[Complete blood count|CBC]]: Increased WBCs count
Line 54: Line 94:
* Elevated [[C-reactive protein|CRP]] levels.
* Elevated [[C-reactive protein|CRP]] levels.
|
|
* Slight ST segment elevation in several leads
* Slight [[ST segment elevation]] in several leads


* Diffuse T wave inversion
* Diffuse [[T wave inversion]]
|
|
* [[Pericardial effusion]]
* [[Cardiac tamponade]]
|-
|-
|[[Amphetamine]]/[[Cocaine]]  
|[[Amphetamine]]/[[Cocaine]] Cardiomyopathy
Cardiomyopathy
|
|
* Illicit drug use
* Illicit drug use
Line 73: Line 114:
* Impaired electrolytes levels
* Impaired electrolytes levels
|
|
* [[ST segment elevation]] in two or more ECG leads
* [[Cardiac arrhythmia]] may be present
|
|
* Chamber dilation
* Regional wall motion abnormalities
* Increased left ventricular mass
* Increased posterior wall thickness
|-
|-
|Arrhythmogenic right ventricular  
|Arrhythmogenic right ventricular  
Line 89: Line 139:
* Imaging modalities as 2D [[echocardiography]] and MRI.
* Imaging modalities as 2D [[echocardiography]] and MRI.
|
|
* [[Epsilon wave]]
* [[T wave inversion]]
* Prolonged [[S wave]] upstroke
* Localised [[QRS complex|QRS]] widening
* [[Paroxysmal ventricular tachycardia]]
|
|
* Dilated, hypokinetic right ventricle
* Prominent apical trabeculae
* Dilatation of RV outflow tract
|-
|-
|Wet [[Beriberi]]
|Wet [[Beriberi]]
Line 103: Line 167:
|
|
* Thiamine replacement test
* Thiamine replacement test
* Reduced urinary thiamine
* Reduced urinary [[thiamine]]
* Reduced erythrocyte [[transketolase]]  and [[thiamine pyrophosphate]] activities.
* Reduced erythrocyte [[transketolase]]  and [[thiamine pyrophosphate]] activities.
|
|In advanced beriberi, [[Congestive heart failure|heart failure]] occurs.
|
 
* Low voltage [[QRS complex]]
* Prolongation of [[QT prolongation|QT interval]].
* [[Left bundle branch block]]
|In advanced beriberi, [[Congestive heart failure|heart failure]] occurs.
 
* Reduced [[ejection fraction]].
* Reduced fractional shortening
* Large cardiac chamber sizes.
* Disturbed regional wall motion
 
<br />
|-
|-
|[[Cardiac tamponade|Cardiac Tamponade]]
|[[Cardiac tamponade|Cardiac Tamponade]]
Line 114: Line 189:
* [[Iatrogenic]] - central line insertion, [[Artificial pacemaker|pacemaker insertion]], and [[Percutaneous coronary intervention|PCI]]
* [[Iatrogenic]] - central line insertion, [[Artificial pacemaker|pacemaker insertion]], and [[Percutaneous coronary intervention|PCI]]
* [[Idiopathic]]
* [[Idiopathic]]
* [[Malignancy]] - [[breast cancer]], [[Kaposi's sarcoma]], [[lung cancer]], [[Lymphoma|lymphomas]]
* [[Malignancy]]
* Penetrating [[trauma]]
* Penetrating [[trauma]]
* [[Pericarditis]]
* [[Pericarditis]]
Line 125: Line 200:
* Cause-related investigations as serum inflammatory markers, diagnostic pericardiocentesis, and [[Gallium Citrate Ga 67|Gallium]] 67 imaging.
* Cause-related investigations as serum inflammatory markers, diagnostic pericardiocentesis, and [[Gallium Citrate Ga 67|Gallium]] 67 imaging.
|
|
|Echocardiography to score the [[European society of cardiology|European Society of Cardiology]] (ESC) Working Group on Myocardial and Pericardial Diseases
* Low voltage [[QRS complex]]
* [[Sinus tachycardia]]
* ECG findings of [[pericarditis]] may be present
|
* [[Pericardial effusion]].
* Swinging of the heart within the effusion
* Reversal of right atrial and right ventricular diastolic transmural pressures.
* Cardiac chamber collapse
|-
|-
|[[Hyperthyroidism]]
|[[Hyperthyroidism]]
Line 145: Line 227:
* Thyroid stimulating antibodies: Elevated only in [[Graves' disease|Grave's disease]]
* Thyroid stimulating antibodies: Elevated only in [[Graves' disease|Grave's disease]]
|
|
|
* [[Sinus tachycardia]]
* [[Atrial fibrillation]]
* High left-ventricular voltage
|The following may be present:
 
* Left ventricular enhanced systolic function
* Enhanced or impaired diastolic function
* [[Congestive heart failure|Heart failure]] with preserved ejection fraction
|-
|-
|[[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
|[[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
Line 163: Line 252:
* [[Syncope]]
* [[Syncope]]
* [[Fatigue]]
* [[Fatigue]]
|The diagnosis is based on
|
* Detecting the cause ([[Thyroid hormone|Thyroid hormones]], [[Blood sugar|blood glucose]], liver and renal function tests, blood [[hemoglobin]])
* [[Genotyping]] (Genetic screening)
* [[Brain natriuretic peptide]] (prognosis)


* Electrocardiogram
*  
*  
|
|
|Echocardiography according to ACCF/[[American Heart Association|AHA]] Guideline for the Diagnosis and Treatment of [[Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy]]
* ST-T wave abnormalities
* Axis deviation (right or left)
* Conduction abnormalities
* [[Sinus bradycardia]] with [[ectopic atrial rhythm]]
* Atrial enlargement
|
* Diastolic dysfunction
* Septal wall thickness of >15 mm
* Narrowing of the LV outflow tract
* Abnormal systolic motion of the anterior leaflet of the mitral valve
|-
|-
|[[Noncompaction cardiomyopathy|Left ventricular noncompaction]]
|[[Noncompaction cardiomyopathy|Left ventricular noncompaction]]
Line 180: Line 280:
* [[Exercise intolerance]]
* [[Exercise intolerance]]
* In infants, [[cyanosis]], dysmorphic features, and [[failure to thrive]]
* In infants, [[cyanosis]], dysmorphic features, and [[failure to thrive]]
|Diagnosis can be based on:
* Echocardiography
* Steady-state free precession MRI, showing prominent trabeculations and a non-compacted to compacted (NC/C) myocardium ratio > 2.3
|
|
* Detection of [[Barth syndrome]] ([[Neutropenia]] and 3-methylgluconic aciduria)
*Genetic screening
|
* Intraventricular [[Left anterior fascicular block|conduction delay]]
* Voltage signs of left [[ventricular hypertrophy]]
* [[Repolarization]] abnormalities
|
|
*Echocardiography
* Steady-state free precession MRI, showing prominent trabeculations and a non-compacted to compacted (NC/C) myocardium ratio > 2.3
|-
|-
|[[Myocarditis]]
|[[Myocarditis]]
Line 202: Line 306:
* Systemic symptoms as [[fever]] and joint pain
* Systemic symptoms as [[fever]] and joint pain
|
|
* Diagnostic Imaging (Echocardiography and MRI).
*[[Creatine kinase]] (CK-MB)
* [[Creatine kinase]] (CK-MB)
* [[Troponin|Cardiac troponin]] I (cTnI) or T (cTnT)  
* [[Troponin|Cardiac troponin]] I (cTnI) or T (cTnT)  
* Increased [[C-reactive protein|CRP]] and [[Erythrocyte sedimentation rate|ESR]]
* Increased [[C-reactive protein|CRP]] and [[Erythrocyte sedimentation rate|ESR]]
Line 209: Line 312:
* Viral antibody titres or autoantibodies (to reach the cause)
* Viral antibody titres or autoantibodies (to reach the cause)
|
|
* [[Sinus tachycardia]]
* Diffuse [[T wave]] inversions
* [[ST segment elevation]]
* Low voltage of the [[QRS]] complexes
* [[Arrhythmias]] such as atrial and ventricular ectopic beats
|
|
* Wall motion abnormalities
* [[Systolic dysfunction]]
* [[Diastolic dysfunction]]
* Changes in image texture on echocardiogram
* [[Pericardial effusion]]
* Functional regurgitation
|-
|-
|[[Restrictive Cardiomyopathies|Restrictive]] Cardiomyopathy
|[[Restrictive Cardiomyopathies|Restrictive]] Cardiomyopathy
Line 227: Line 341:
* Low [[QRS complex|QRS]] voltages
* Low [[QRS complex|QRS]] voltages
* Conduction abnormalities.
* Conduction abnormalities.
|Wall and valvular thickening and sparkling myocardium.
|
* Wall and valvular thickening  
* Sparkling myocardium.
|}
|}



Latest revision as of 17:55, 29 December 2019

Dilated cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Classification

Causes

Differentiating Dilated cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Dilated cardiomyopathy differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Dilated cardiomyopathy differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dilated cardiomyopathy differential diagnosis

CDC on Dilated cardiomyopathy differential diagnosis

Dilated cardiomyopathy differential diagnosis in the news

Blogs on Dilated cardiomyopathy differential diagnosis

Directions to Hospitals Treating Dilated cardiomyopathy

Risk calculators and risk factors for Dilated cardiomyopathy differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdelrahman Ibrahim Abushouk, MD[2]

Overview

Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular acute coronary syndrome, other cardiomyopathies (hypertrophic, restrictive, and ARVC/D), myocarditis, pericarditis, and cardiac toxicities.

Differentiating Dilated Cardiomyopathy from other Diseases

Dilated cardiomyopathy should be differentiated from other causes of cardiac dysfunction, in particular acute coronary syndrome, other cardiomyopathies (hypertrophic, restrictive, and ARVC/D), myocarditis, pericarditis, and cardiac toxicities.[1][2][3][4]

Disorders Etiology Clinical Presentation Laboratory Findings Electrocardiogram Echocardiography
Dilated Cardiomyopathy
  • S2 at the base
  • Ventricular and atrial dilatation
  • Increased left ventricular mass
  • Global reduction in systolic function
  • Focal wall motion abnormalities
Acute Coronary Syndrome
  • Elevated blood troponin levels (after 6 hours of attack onset)
  • Elevated blood CK-MB levels
Acute Pericarditis
  • CBC: Increased WBCs count
  • Modest increase in CK-MB
  • Elevated CRP levels.
Amphetamine/Cocaine Cardiomyopathy
  • Illicit drug use
  • Drug and toxicology screen
  • Elevated serum CK (rhabdomyolysis)
  • Impaired electrolytes levels
  • Chamber dilation
  • Regional wall motion abnormalities
  • Increased left ventricular mass
  • Increased posterior wall thickness
Arrhythmogenic right ventricular

cardiomyopathy (ARVC/D)

Diagnostic criteria are based on:
  • Localised QRS widening
  • Dilated, hypokinetic right ventricle
  • Prominent apical trabeculae
  • Dilatation of RV outflow tract
Wet Beriberi
  • Inadequate thiamine intake (rice-based foods, alcoholism, and malnutrition)
  • Increased thiamine loss (protracted vomiting)
  • Inadequate absorption (after bariatric surgery or genetic mutation)
In advanced beriberi, heart failure occurs. In advanced beriberi, heart failure occurs.
  • Reduced ejection fraction.
  • Reduced fractional shortening
  • Large cardiac chamber sizes.
  • Disturbed regional wall motion


Cardiac Tamponade
  • Acute tamponade: Cardiogenic shock, hypotension, cold extremities, peripheral cyanosis, and decreased urine output.
  • Subacute tamponade: Peripheral edema with gradual progression to the aforementioned clinical picture.
  • Increased serum CK-MB and troponin
  • Cause-related investigations as serum inflammatory markers, diagnostic pericardiocentesis, and Gallium 67 imaging.
  • Pericardial effusion.
  • Swinging of the heart within the effusion
  • Reversal of right atrial and right ventricular diastolic transmural pressures.
  • Cardiac chamber collapse
Hyperthyroidism
  • Elevated T3 and T4 hormones
  • TSH: Reduced in 1ry and Elevated in 2ry hyperthyroidism.
  • Thyroid stimulating antibodies: Elevated only in Grave's disease
The following may be present:
  • Left ventricular enhanced systolic function
  • Enhanced or impaired diastolic function
  • Heart failure with preserved ejection fraction
Hypertrophic Cardiomyopathy
  • Diastolic dysfunction
  • Septal wall thickness of >15 mm
  • Narrowing of the LV outflow tract
  • Abnormal systolic motion of the anterior leaflet of the mitral valve
Left ventricular noncompaction
  • Echocardiography
  • Steady-state free precession MRI, showing prominent trabeculations and a non-compacted to compacted (NC/C) myocardium ratio > 2.3
Myocarditis
Restrictive Cardiomyopathy Systemic diseases, such as
  • Low QRS voltages
  • Conduction abnormalities.
  • Wall and valvular thickening
  • Sparkling myocardium.

References

  1. Amosova EN (1992). "[Differential diagnosis of dilated cardiomyopathy]". Klin Med (Mosk). 70 (3–4): 14–9. PMID 1507837.
  2. Schultheiss HP, Fairweather D, Caforio ALP, Escher F, Hershberger RE, Lipshultz SE; et al. (2019). "Dilated cardiomyopathy". Nat Rev Dis Primers. 5 (1): 32. doi:10.1038/s41572-019-0084-1. PMID 31073128.
  3. Gurevich MA, Gordienko BV (2003). "[Dilated and ischemic cardiomyopathy: differential diagnosis]". Klin Med (Mosk). 81 (9): 68–71. PMID 14598597.
  4. Gurevich MA, Gordienko BV (2003). "[Dilated and ischemic cardiomyopathy: differential diagnosis]". Klin Med (Mosk). 81 (9): 68–71. PMID 14598597.


Template:WH Template:WS